1Culine S.The present and future of combination chemotherapy in bladder cancer[].Seminars in Oncology.2002
2Yang MH,Yen CC,Chang YH,et al.Single agent paclitaxel as a first-line therapy in advanced urothelial carcinoma:its efficacy and safety in pa tients even with pretreatment renal insufficiency[].Japanese Journal of Clinical Oncology.2000
3Raghavan D.Progress in the chemotherapy of metastatic cancer of the urinary tract[].Cancer.2003
4Nygren P,Csoka K,Larsson R,et al.Activity of stadard and investigational cytotoxic drugs in primary cultures of tumore cells from patients with kidney and urinary bladder carcinomas[].Journal d’Urologie.1999
5Bellmunt J,Guillem V,Pav-Ares L,et al.Gemcitabine/paclitaxel-based three-drug regimens in advancod urotholial cancer[].European Journal of Cancer.2000
7Kanat O,Evernsel T,Baran I,et al.Protective effect of amifostine against toxicity ofpaelitaxel in non-small cell lung cancer:a single center randomized study[J].MedOncol,2003,20(3):237-245.
